Clinical Application of Detecting 21-Gene Recurrence Score in Predicating Prognosis and Therapy Response of Patients with Breast Cancer from Two Medical Centers
Guodong Xiao(First Affiliated Hospital of Xi'an Jiaotong University), Xin Sun(Thomas Jefferson University), Ning Du(First Affiliated Hospital of Xi'an Jiaotong University), Sida Qin(Harbin Medical University), Gang Li(First Affiliated Hospital of Xi'an Jiaotong University), Jing Zhang(First Affiliated Hospital of Xi'an Jiaotong University), Jinying Meng(Taiyuan University of Science and Technology), Hong Ren(First Affiliated Hospital of Xi'an Jiaotong University), Shou‐Ching Tang(University of Mississippi Medical Center), Chongwen Xu(First Affiliated Hospital of Xi'an Jiaotong University), Jichang Wang(Shenyang Aerospace University)
Cited by 5
Related Papers
ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases
|Clinical Cancer Research|2020|242
Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation
|Journal of Experimental & Clinical Cancer Research|2019|141
Suppression of tumor angiogenesis by metformin treatment<i>via</i>a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis
|Oncotarget|2015|107
Carbon Support Enhanced Mass Transfer and Metal–Support Interaction Promoted Activation for Low-Concentrated Nitric Oxide Electroreduction to Ammonia
|Journal of the American Chemical Society|2024|95
M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way
|Journal of Experimental & Clinical Cancer Research|2021|92